FundedIQ
Biotechnology

Aida Oncology: Funding, Investors & Team (Sep 2026)

AIDA Oncology employs machine learning to determine the most suitable cancer medication for individual patients by studying their tumor's RNA expression pattern.

aidaoncology.com LinkedIn Birkerød, Denmark 1-10 employees
Total raised
$530k
Rounds
1
Latest
Pre-Seed
Mar 2023

Aida Oncology has raised $530k across 1 funding round on record, the most recent a Pre-Seed of $530k announced in Mar 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Aida Oncology Company Profile and Key Stats

Total funding raised
$530k
across 1 round on record
Funding rounds on record
1
Latest funding round
Pre-Seed
$530k in Mar 2023
Employees
1-10
reported band
Headquarters
Birkerød, Denmark

Latest funding round on record: Mar 2023.

Aida Oncology Funding Rounds

Date
Round
Amount
Pre-Seed
$530k

Aida Oncology Founders and Leadership Team

Name
Role
Contact
Peter Buhl Jensen
Founder
Locked

Contact details for the Aida Oncology team: 1 of 1 has an email address on file.

Start 14-day free trial →

Aida Oncology Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
371
$3.8M
5,801
$600K

Aida Oncology's latest round of $530k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Aida Oncology in Biotechnology and Birkerød

Companies Similar to Aida Oncology

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…

Undisclosed round $3.1M

Alcolase is a Danish life science start-up that specializes in alcohol flushing.

Seed $1.7M

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…

Series C $75.0M

ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution

Angel $240k

Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…

Seed $1.5M

Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…

Seed $1.5M

Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…

Undisclosed round $275M

Pioneering new sustainable bio-based ingredients

Series A $5.9M

Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…

Undisclosed round $1.0M

EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…

Undisclosed round $7.1M

Fida Biosystems is a technology that provides the detection and characterization of proteins and…

Series A $5.9M

Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…

Undisclosed round $8.1M

Aida Oncology Funding FAQs

What does Aida Oncology do?

AIDA Oncology employs machine learning to determine the most suitable cancer medication for individual patients by studying their tumor's RNA expression pattern.

How much funding has Aida Oncology raised?

Aida Oncology has raised $530k across 1 round on record. The most recent is a Pre-Seed of $530k announced in Mar 2023.

When did Aida Oncology last raise funding?

Aida Oncology's most recent funding round on record is a Pre-Seed of $530k, announced in Mar 2023.

Who founded Aida Oncology?

FundedIQ lists Peter Buhl Jensen (Founder) at Aida Oncology.

Where is Aida Oncology headquartered?

Aida Oncology is based in Birkerød, Hovedstaden, Denmark.

How many employees does Aida Oncology have?

Aida Oncology is in the 1-10 employee band.

How does Aida Oncology's funding compare to other Biotechnology startups?

Aida Oncology's latest round of $530k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Aida Oncology Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aida Oncology is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.